SofWave Medical (SOFW) 24th Annual Needham Virtual Healthcare Conference summary

Market positioning and technology

• Offers non-invasive, next-generation ultrasound technology for skin lifting, tightening, and toning, with broad FDA clearances for face and body treatments.

• Achieved significant traction and adoption by global key opinion leaders, with strong clinical results and high patient satisfaction.

• Differentiates through consistent outcomes, superior safety profile, and minimal downtime, making treatments delegatable and appealing to providers.

• Supported by an experienced management team with a track record in aesthetics and rapid execution.

• Addresses growing demand for aesthetic treatments across demographics, offering alternatives to invasive procedures with fewer complications.

Business model and financial performance

• Utilizes a frictionless business model: providers purchase devices and then buy virtual consumables (pulses) as needed, similar to a cell phone plan.

• Device ASP is below $100,000, with high-margin pulse sales representing 35%-40% of revenue, and average provider ROI achieved in 4-6 months.

• Maintains premium pricing with minimum advertised price policies, protecting provider margins and offsetting price erosion seen in competing technologies.

• Reported 69% CAGR since launch, with Q4 revenue up 20% and pulse revenue up 63% year-over-year, reaching $23 million.

• Achieved profitability and positive cash flow in recent quarters, with gross margins at 77% and a lean, scalable structure.

Growth strategy and market expansion

• Direct sales in the U.S. and U.K., with distribution in over 40 countries and plans to expand into Japan, China, and Brazil.

• Invests heavily in brand awareness, digital marketing, and practice development to drive procedure growth and patient retention.

• Leveraged organic celebrity endorsements and influencer marketing, resulting in significant increases in web traffic and inbound leads.

• Focuses on continuous product innovation, adding new applicators and devices to address a broad range of indications and patient needs.

• Sees GLP-1 agonists and weight loss trends as catalysts for increased demand in skin tightening and muscle toning.